Skip to content

A Randomized Controlled Trial of AttraX® Putty vs. conventional open-wedge osteotomy without gap filler in open-wedge osteotomy

A Randomized Controlled Trial of AttraX® Putty vs. conventional open-wedge osteotomy without gap filler in open-wedge osteotomy - AXOS

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON53187
Enrollment
40
Registered
2023-07-19
Start date
2023-09-20
Completion date
Unknown
Last updated
2024-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Standsafwijking arthrosis Unicompartimental osteoarthritis

Interventions

According to a randomization scheme, the osteotomy gap will be filled with either the synthetic ceramic material AttraX® Putty or without a gap filler (conventional method).

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Patients above 18 years with an indication for an open-wedge osteotomy of the femur, tibia or double level due to unicompartimental OA. 2. Comply with all aspects of the treatment, including CT scans, Xrays and 1-year follow-up 3. Informed consent

Exclusion criteria

Exclusion criteria: 1. Osteotomy for indication of cartilage treatment or other knee surgeries than unicompartimental OA 2. Correction using an open wedge above 10 mm 3. Pregnant women at the time of enrolment or women who are planning to become pregnant during the duration of the study 4. Inability to communicate in Dutch or English

Design outcomes

Primary

MeasureTime frame
The main study endpoint is the mean NRS pain during the first week postoperative.

Secondary

MeasureTime frame
The secondary study endpoints are faster accelerated rehabilitation/regaining function, reduction of local blood loss, accelerated, bone union, and comparable surgical feasibility

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)